Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
20 March 2018 (08:30 - 12:30)
Organised by:
Abstract
About the speaker

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
39 More presentations in this session
Access the full session
The Event
EHRA 2018
20 March 2018
08:30 CET
